Orthofix Medical Inc Revenue Growth Rates (OFIX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Orthofix Medical Inc   (NASDAQ: OFIX)
 

OFIX's Revenue Growth by Quarter and Year

Orthofix Medical Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OFIX Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 210.93
1st Quarter March 196.55
FY 407.48

OFIXs Annual Revenue
Orthofix Medical Inc 's Revenue in the fiscal year 2025 $ 822.02 millions
Orthofix Medical Inc 's Revenue in the fiscal year 2024 $ 798.89 millions
Orthofix Medical Inc 's Revenue in the fiscal year 2023 $ 746.27 millions
Orthofix Medical Inc 's Revenue in the fiscal year 2022 $ 460.71 millions
Orthofix Medical Inc 's Revenue in the fiscal year 2021 $ 464.48 millions




OFIX Revenue second quarter 2026 Y/Y Growth Comment
Orthofix Medical Inc achieved in the second quarter 2026, above Company average Revenue improvement of 4.15% year on year, to $ 210.93 millions.

Looking into second quarter 2026 results within Medical Equipment & Supplies industry 118 other companies have achieved higher Revenue growth. While Orthofix Medical Inc ' s Revenue increase of 4.15% ranks overall at the positon no. 2348 in the second quarter 2026.


OFIX Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 1.61 % 8.01 % 64.25 %
3rd Quarter September - 4.83 % 6.69 % 61.19 %
2nd Quarter June 4.15 % 2.42 % 6 % 58 %
1st Quarter March 1.51 % 2.86 % 7.44 % 64.63 %
FY   - 2.9 % 7.05 % -

Financial Statements
Orthofix Medical Inc 's second quarter 2026 Revenue $ 210.93 millions OFIX's Income Statement
Orthofix Medical Inc 's second quarter 2025 Revenue $ 202.53 millions Quarterly OFIX's Income Statement


OFIX Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - 7.21 % 10.6 % 9.25 %
3rd Quarter September - 1.48 % -0.86 % -1.5 %
2nd Quarter June 7.32 % 4.6 % 5.05 % 6.48 %
1st Quarter March -10.8 % -10.71 % -6.24 % 43.34 %
FY (Year on Year)   - 2.9 % 7.05 % -


Back to OFIX Growth rate Comparisons >> Back to OFIX Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #119
Healthcare Sector #342
Overall #2348

Revenue Y/Y Growth Statistics
High Average Low
65.99 % 4.1 % -36.87 %
 
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #119
Healthcare Sector #342
Overall #2348
Revenue Y/Y Growth Statistics
High Average Low
65.99 % 4.1 % -36.87 %
 

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Orthofix Medical Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
51.75 % 1.35 % -30.23 %
(Sep 30 2020)  


OFIX's II. Quarter Q/Q Revenue Comment
Orthofix Medical Inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 7.32%, to $ 210.93 millions, from $196.55 millions in the first quarter.
OFIX is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Orthofix Medical Inc 's Revenue growth quarter on quarter, overall rank is 981.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #148
Overall #981
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #41
Healthcare Sector #148
Overall #981
Revenue Q/Q Growth Statistics
High Average Low
51.75 % 1.35 % -30.23 %
(Sep 30 2020)  


OFIX's II. Quarter Q/Q Revenue Comment
Orthofix Medical Inc achieved in the II. Quarter 2026 above company average sequential Revenue increase of 7.32%, to $ 210.93 millions, from $196.55 millions in the first quarter.
OFIX is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.

Within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Orthofix Medical Inc 's Revenue growth quarter on quarter, overall rank is 981.


Orthofix Medical Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 833.34 $ 824.94 $ 822.02 $ 818.52 $ 809.05
Y / Y Revenue Growth (TTM) 3 % 2.57 % 2.9 % 4.56 % 5 %
Year on Year Revenue Growth Overall Ranking # 2377 # 2616 # 1948 # 1830 # 1683
Seqeuential Revenue Change (TTM) 1.02 % 0.36 % 0.43 % 1.17 % 0.59 %
Seq. Revenue Growth (TTM) Overall Ranking # 2377 # 2616 # 1948 # 1830 # 1683


Cumulative Revenue growth Comment
Although Orthofix Medical Inc 's Annual Revenue growth year on year were below company's average 4.11% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3% year on year, from 2.57% in Mar 31 2026.

In the Healthcare sector 311 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2377, from total ranking in previous quarter at 2616.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 312
Overall # 2074

Revenue TTM Y/Y Growth Statistics
High Average Low
61.98 %
 4.11 %
-21.69 %
(Dec 31 2023)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 372
S&P 500 # 2584
Cumulative Revenue growth Comment
Although Orthofix Medical Inc 's Annual Revenue growth year on year were below company's average 4.11% , Revenue announced in the Jun 30 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 3% year on year, from 2.57% in Mar 31 2026.

In the Healthcare sector 311 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2377, from total ranking in previous quarter at 2616.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 114
Healthcare Sector # 312
Overall # 2074

Revenue TTM Y/Y Growth Statistics
High Average Low
61.98 %
4.11 %
-21.69 %
(Dec 31 2023)  


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 138
Sector # 372
S&P 500 # 2584




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
OFIX's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Agilon Health Inc 7.15%$ 7.151 millions
Tenet Healthcare Corp6.77%$ 6.773 millions
Henry Schein Inc 6.73%$ 6.728 millions
Collegium Pharmaceutical Inc 6.67%$ 6.668 millions
Mallinckrodt Plc6.62%$ 6.617 millions
Johnson and Johnson6.60%$ 6.600 millions
Prestige Consumer Healthcare Inc 6.57%$ 6.569 millions
Msa Safety Inc6.25%$ 6.252 millions
Pacira Biosciences inc 6.24%$ 6.240 millions
Globus Medical Inc 5.94%$ 5.940 millions
Labcorp Holdings Inc 5.78%$ 5.778 millions
Tandem Diabetes Care Inc 5.77%$ 5.768 millions
Bristol myers Squibb Company5.74%$ 5.738 millions
Haemonetics Corporation5.65%$ 5.646 millions
Progyny Inc 5.58%$ 5.584 millions
Cytek Biosciences Inc 5.57%$ 5.566 millions
Amphastar Pharmaceuticals Inc 5.44%$ 5.441 millions
Becton Dickinson And Company5.44%$ 5.438 millions
Bruker Corporation5.22%$ 5.220 millions
Davita Inc 5.17%$ 5.165 millions
Park Dental Partners Inc 5.10%$ 5.102 millions
Lumexa Imaging Holdings Inc 5.08%$ 5.076 millions
Merck and Co Inc 5.07%$ 5.068 millions
Cv Sciences Inc 4.96%$ 4.958 millions
Viatris Inc 4.88%$ 4.877 millions
Fulgent Genetics Inc 4.86%$ 4.855 millions
Zimmer Biomet Holdings Inc 4.80%$ 4.799 millions
Mettler toledo International Inc 4.48%$ 4.485 millions
Phibro Animal Health Corporation4.40%$ 4.405 millions
Align Technology inc 4.35%$ 4.355 millions


About Orthofix Medical Inc Revenue Growth Rates (OFIX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Orthofix Medical Inc (CIK 884624).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001193125-26-333822
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Orthofix Medical Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.